학술논문

Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries
Document Type
Article
Author
Sharmin, SifatRoos, IzanneMalpas, Charles BIaffaldano, PietroSimone, MartaFilippi, MassimoKubala Havrdova, EvaOzakbas, SerkanBrescia Morra, VincenzoAlroughani, RaedZaffaroni, MauroPatti, FrancescoEichau, SaraSalemi, GiuseppeDi Sapio, AlessiaInglese, MatildePortaccio, EmilioTrojano, MariaAmato, Maria PiaKalincik, TomasHorakova, DanaPrat, AlexandreGirard, MarcDuquette, PierreBoz, CavitPozzilli, CarloCocco, EleonoraGallo, PaoloYamout, BassemKhoury, Samia J.Lugaresi, AlessandraOnofrj, MarcoLus, GiacomoClerici, Valentina TorriManiscalco, Giorgia TeresaRomano, SilviaTortorella, CarlaValentino, PaolaRovaris, MarcoShaygannejad, VahidFerraro, DianaVianello, MarikaGrammond, PierreBergamaschi, RobertoGallo, AntonioCavalla, PaolaSa, Maria JoseLechner-Scott, JeannettePesci, IlariaBuzzard, KatherineGouider, RiadhMrabet, SalouaAguglia, UmbertoConte, AntonellaAvolio, CarloBellantonio, PaoloJohn, NevinCartechini, ElisabettaDe Robertis, FrancescaFerraro, ElisabettaWeinstock-Guttman, BiancaBarcella, ValeriaVan der Walt, AnnekeButzkueven, HelmutConiglio, Maria GabriellaGranella, FrancoKuhle, JensMarfia, Girolama AlessandraLaureys, GuyVan Hijfte, LiesbethMaimone, DavideGazzola, PaolaBlanco, YolandaTurkoglu, RecaiMontepietra, SaraSpitaleri, Danielevan Pesch, VincentGerlach, OliverPrevost, JulieAmpapa, RadekSoysal, AysunAltintas, AyseRini, AugustoSolaro, ClaudioProtti, AlessandraFoschi, MatteoSurcinelli, AndreaGatto, MauriziaMascoli, NerinaDe Riz, MilenaRealmuto, SabrinaRossi, PatriziaTotaro, RoccoBarnett, MichaelOh, JiwonNasuelli, DavideRamo-Tello, CristinaSanchez-Menoyo, Jose LuisAl-Harbi, TalalFioretti, CristinaBucello, SebastianoCargnelutti, DanielaVukusic, Sandra
Source
The Lancet Child & Adolescent Health; May 2024, Vol. 8 Issue: 5 p348-357, 10p
Subject
Language
ISSN
23524642; 23524650
Abstract
High-efficacy disease-modifying therapies have been proven to slow disability accrual in adults with relapsing–remitting multiple sclerosis. However, their impact on disability worsening in paediatric-onset multiple sclerosis, particularly during the early phases, is not well understood. We evaluated how high-efficacy therapies influence transitions across five disability states, ranging from minimal disability to gait impairment and secondary progressive multiple sclerosis, in people with paediatric-onset multiple sclerosis.